Taltirelina (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Taltirelina" in Italian language version.

Last modified: 17:27:08, 3 July 2026 (UTC)

Ref.Un. Ref.Website

Global rank Italian rank

88nih.gov

5^th place

6^th place

77doi.org

2^nd place

3^rd place

44archive.org

6^th place

2^nd place

33oadoi.org

612^th place

14^th place

archive.org (Global: 6^th place; Italian: 2^nd place)

Asai H, Asahi T, Yamamura M, Yamauchi-Kohno R, Saito A, Lack of behavioral tolerance by repeated treatment with taltirelin hydrate, a thyrotropin-releasing hormone analog, in rats, in Pharmacology, Biochemistry, and Behavior, vol. 82, n. 4, dicembre 2005, pp. 646–51, DOI:10.1016/j.pbb.2005.11.004, PMID 16368129.
Urayama A, Yamada S, Kimura R, Zhang J, Watanabe Y, Neuroprotective effect and brain receptor binding of taltirelin, a novel thyrotropin-releasing hormone (TRH) analogue, in transient forebrain ischemia of C57BL/6J mice, in Life Sciences, vol. 72, 4–5, dicembre 2002, pp. 601–7, DOI:10.1016/S0024-3205(02)02268-3, PMID 12467901.
Tanabe M, Tokuda Y, Takasu K, Ono K, Honda M, Ono H, The synthetic TRH analogue taltirelin exerts modality-specific antinociceptive effects via distinct descending monoaminergic systems, in British Journal of Pharmacology, vol. 150, n. 4, febbraio 2007, pp. 403–14, DOI:10.1038/sj.bjp.0707125, PMC 2189720, PMID 17220907.
Takeuchi Y, Miyanomae Y, Komatsu H, Oomizono Y, Nishimura A, Okano S, Nishiki T, Sawada T, Efficacy of thyrotropin-releasing hormone in the treatment of spinal muscular atrophy, in Journal of Child Neurology, vol. 9, n. 3, luglio 1994, pp. 287–9, DOI:10.1177/088307389400900313, PMID 7930408.

doi.org (Global: 2^nd place; Italian: 3^rd place)

dx.doi.org

Asai H, Asahi T, Yamamura M, Yamauchi-Kohno R, Saito A, Lack of behavioral tolerance by repeated treatment with taltirelin hydrate, a thyrotropin-releasing hormone analog, in rats, in Pharmacology, Biochemistry, and Behavior, vol. 82, n. 4, dicembre 2005, pp. 646–51, DOI:10.1016/j.pbb.2005.11.004, PMID 16368129.
Yamamura M, Suzuki M, Matsumoto K, [Synthesis and pharmacological action of TRH analog peptide (Taltirelin)], in Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica, vol. 110, Suppl 1, ottobre 1997, pp. 33P–38P, DOI:10.1254/fpj.110.supplement_33, PMID 9503402.
Urayama A, Yamada S, Kimura R, Zhang J, Watanabe Y, Neuroprotective effect and brain receptor binding of taltirelin, a novel thyrotropin-releasing hormone (TRH) analogue, in transient forebrain ischemia of C57BL/6J mice, in Life Sciences, vol. 72, 4–5, dicembre 2002, pp. 601–7, DOI:10.1016/S0024-3205(02)02268-3, PMID 12467901.
Tanabe M, Tokuda Y, Takasu K, Ono K, Honda M, Ono H, The synthetic TRH analogue taltirelin exerts modality-specific antinociceptive effects via distinct descending monoaminergic systems, in British Journal of Pharmacology, vol. 150, n. 4, febbraio 2007, pp. 403–14, DOI:10.1038/sj.bjp.0707125, PMC 2189720, PMID 17220907.
Takeuchi Y, Miyanomae Y, Komatsu H, Oomizono Y, Nishimura A, Okano S, Nishiki T, Sawada T, Efficacy of thyrotropin-releasing hormone in the treatment of spinal muscular atrophy, in Journal of Child Neurology, vol. 9, n. 3, luglio 1994, pp. 287–9, DOI:10.1177/088307389400900313, PMID 7930408.
Tzeng AC, Cheng J, Fryczynski H, Niranjan V, Stitik T, Sial A, Takeuchi Y, Foye P, DePrince M, Bach JR, A study of thyrotropin-releasing hormone for the treatment of spinal muscular atrophy: a preliminary report, in American Journal of Physical Medicine & Rehabilitation, vol. 79, n. 5, 2000, pp. 435–40, DOI:10.1097/00002060-200009000-00005, PMID 10994885.
Kato Z, Okuda M, Okumura Y, Arai T, Teramoto T, Nishimura M, Kaneko H, Kondo N, Oral administration of the thyrotropin-releasing hormone (TRH) analogue, taltireline hydrate, in spinal muscular atrophy, in Journal of Child Neurology, vol. 24, n. 8, agosto 2009, pp. 1010–2, DOI:10.1177/0883073809333535, PMID 19666885.

nih.gov (Global: 5^th place; Italian: 6^th place)

ncbi.nlm.nih.gov

Fukuchi I, Asahi T, Kawashima K, Kawashima Y, Yamamura M, Matsuoka Y, Kinoshita K, Effects of taltirelin hydrate (TA-0910), a novel thyrotropin-releasing hormone analog, on in vivo dopamine release and turnover in rat brain, in Arzneimittel-Forschung, vol. 48, n. 4, aprile 1998, pp. 353–9, PMID 9608876.
Asai H, Asahi T, Yamamura M, Yamauchi-Kohno R, Saito A, Lack of behavioral tolerance by repeated treatment with taltirelin hydrate, a thyrotropin-releasing hormone analog, in rats, in Pharmacology, Biochemistry, and Behavior, vol. 82, n. 4, dicembre 2005, pp. 646–51, DOI:10.1016/j.pbb.2005.11.004, PMID 16368129.
Yamamura M, Suzuki M, Matsumoto K, [Synthesis and pharmacological action of TRH analog peptide (Taltirelin)], in Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica, vol. 110, Suppl 1, ottobre 1997, pp. 33P–38P, DOI:10.1254/fpj.110.supplement_33, PMID 9503402.
Urayama A, Yamada S, Kimura R, Zhang J, Watanabe Y, Neuroprotective effect and brain receptor binding of taltirelin, a novel thyrotropin-releasing hormone (TRH) analogue, in transient forebrain ischemia of C57BL/6J mice, in Life Sciences, vol. 72, 4–5, dicembre 2002, pp. 601–7, DOI:10.1016/S0024-3205(02)02268-3, PMID 12467901.
Tanabe M, Tokuda Y, Takasu K, Ono K, Honda M, Ono H, The synthetic TRH analogue taltirelin exerts modality-specific antinociceptive effects via distinct descending monoaminergic systems, in British Journal of Pharmacology, vol. 150, n. 4, febbraio 2007, pp. 403–14, DOI:10.1038/sj.bjp.0707125, PMC 2189720, PMID 17220907.
Takeuchi Y, Miyanomae Y, Komatsu H, Oomizono Y, Nishimura A, Okano S, Nishiki T, Sawada T, Efficacy of thyrotropin-releasing hormone in the treatment of spinal muscular atrophy, in Journal of Child Neurology, vol. 9, n. 3, luglio 1994, pp. 287–9, DOI:10.1177/088307389400900313, PMID 7930408.
Tzeng AC, Cheng J, Fryczynski H, Niranjan V, Stitik T, Sial A, Takeuchi Y, Foye P, DePrince M, Bach JR, A study of thyrotropin-releasing hormone for the treatment of spinal muscular atrophy: a preliminary report, in American Journal of Physical Medicine & Rehabilitation, vol. 79, n. 5, 2000, pp. 435–40, DOI:10.1097/00002060-200009000-00005, PMID 10994885.
Kato Z, Okuda M, Okumura Y, Arai T, Teramoto T, Nishimura M, Kaneko H, Kondo N, Oral administration of the thyrotropin-releasing hormone (TRH) analogue, taltireline hydrate, in spinal muscular atrophy, in Journal of Child Neurology, vol. 24, n. 8, agosto 2009, pp. 1010–2, DOI:10.1177/0883073809333535, PMID 19666885.

oadoi.org (Global: 612^th place; Italian: 14^th place)

Yamamura M, Suzuki M, Matsumoto K, [Synthesis and pharmacological action of TRH analog peptide (Taltirelin)], in Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica, vol. 110, Suppl 1, ottobre 1997, pp. 33P–38P, DOI:10.1254/fpj.110.supplement_33, PMID 9503402.
Tzeng AC, Cheng J, Fryczynski H, Niranjan V, Stitik T, Sial A, Takeuchi Y, Foye P, DePrince M, Bach JR, A study of thyrotropin-releasing hormone for the treatment of spinal muscular atrophy: a preliminary report, in American Journal of Physical Medicine & Rehabilitation, vol. 79, n. 5, 2000, pp. 435–40, DOI:10.1097/00002060-200009000-00005, PMID 10994885.
Kato Z, Okuda M, Okumura Y, Arai T, Teramoto T, Nishimura M, Kaneko H, Kondo N, Oral administration of the thyrotropin-releasing hormone (TRH) analogue, taltireline hydrate, in spinal muscular atrophy, in Journal of Child Neurology, vol. 24, n. 8, agosto 2009, pp. 1010–2, DOI:10.1177/0883073809333535, PMID 19666885.

Taltirelina (Italian Wikipedia)

archive.org (Global: 6th place; Italian: 2nd place)

doi.org (Global: 2nd place; Italian: 3rd place)